Technical Analysis for RHY - Rhythm Biosciences Limited
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.075 | 0.00% | 0.000 |
RHY closed down 3.85 percent on Wednesday, May 15, 2024, on 1.14 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| 180 Bearish Setup | Bearish Swing Setup | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | -3.85% | |
| Narrow Range Bar | Range Contraction | -3.85% | |
| Inside Day | Range Contraction | -3.85% | |
| Gapped Down | Weakness | -3.85% | |
| Oversold Stochastic | Weakness | -3.85% | |
| Stochastic Buy Signal | Bullish | -7.41% |
| Alert | Time |
|---|---|
| New 52 Week Low | 40 minutes ago |
| Down 1 ATR | about 24 hours ago |
| Fell Below Previous Day's Low | about 24 hours ago |
| Down 3% | about 24 hours ago |
| Down 2% | about 24 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Rhythm Biosciences Ltd is an Australia-based company, which develops a medical diagnostic technology for colorectal cancer, ColoStat. ColoStat technology is a blood test for screening colorectal cancer. The test is an immunoassay biochemical test that detects the presence of multiple protein biomarkers for colorectal cancer. It detects the colorectal cancer at all stages including the early ones.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Chemical Cancer Clinical Medicine Protein Screening Biomarkers Immunoassay Infectious Causes Of Cancer Medical Diagnostic Biomarker
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Chemical Cancer Clinical Medicine Protein Screening Biomarkers Immunoassay Infectious Causes Of Cancer Medical Diagnostic Biomarker
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.83 |
| 52 Week Low | 0.075 |
| Average Volume | 121,105 |
| 200-Day Moving Average | 0.195 |
| 50-Day Moving Average | 0.090 |
| 20-Day Moving Average | 0.084 |
| 10-Day Moving Average | 0.080 |
| Average True Range | 0.003 |
| RSI (14) | 34.64 |
| ADX | 23.9 |
| +DI | 15.084 |
| -DI | 38.827 |
| Chandelier Exit (Long, 3 ATRs) | 0.085 |
| Chandelier Exit (Short, 3 ATRs) | 0.083 |
| Upper Bollinger Bands | 0.094 |
| Lower Bollinger Band | 0.074 |
| Percent B (%b) | 0.07 |
| BandWidth | 24.344 |
| MACD Line | -0.004 |
| MACD Signal Line | -0.004 |
| MACD Histogram | -0.0004 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.080 | ||||
| Resistance 3 (R3) | 0.080 | 0.079 | 0.079 | ||
| Resistance 2 (R2) | 0.079 | 0.078 | 0.079 | 0.078 | |
| Resistance 1 (R1) | 0.077 | 0.077 | 0.077 | 0.077 | 0.078 |
| Pivot Point | 0.076 | 0.076 | 0.076 | 0.076 | 0.076 |
| Support 1 (S1) | 0.074 | 0.075 | 0.074 | 0.074 | 0.072 |
| Support 2 (S2) | 0.073 | 0.074 | 0.073 | 0.072 | |
| Support 3 (S3) | 0.071 | 0.073 | 0.071 | ||
| Support 4 (S4) | 0.071 |
